Page breadcrumb nav

VAERS Report 2156833

Case Report Section

Vaer Report Details

Age: NA

Gender: Female

State: Outside US

Patient Died?
No
Vaccine information

Name: COVID19 (COVID19 (PFIZER-BIONTECH))

Type: Coronavirus 2019 vaccine

Manufacturer: PFIZER

Lot: fn5254


Date report was received
2022-03-04
Date form completed
Date Vaccinated
2022-02-10
Date of Onset
0
Number of days (onset date – vaccination date)
0
Adverse Event Description

rib pain/this time is more intense and constant; rib pain/this time is more intense and constant; covid-19 vaccine astrazeneca/comrinaty; covid-19 vaccine astrazeneca/comrinaty; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory agency. regulatory number: gb-mhra-webcovid-202202181801309620-j1dht. other case identifier(s): gb-mhra-adr 26622004. a 45 year-old female patient (not pregnant) received bnt162b2 (comirnaty), administration date 10feb2022 (lot number: fn5254) as dose 3 (booster), single for covid-19 immunisation. relevant medical history included: "radiotherapy" (unspecified if ongoing); "cancer", start date: aug2019 (unspecified if ongoing), notes: with chemotherapy and radiotherapy; "neoplasm" (unspecified if ongoing), notes: recently had treatment for cancer, leukaemia or lymphoma (radiotherapy or chemotherapy); "chemotherapy" (unspecified if ongoing); "breast cancer" (unspecified if ongoing). patient last menstrual period was on 10feb2022. patient has not had symptoms associated with covid-19. patient is not currently breastfeeding. concomitant medication(s) included: tamoxifen [tamoxifen citrate] taken for breast cancer, start date: 01may2019 (ongoing). vaccination history included: covid-19 vaccine astrazeneca (dose 1), administration date: 06may2021, for covid-19 immunisation, reaction(s): "rib pain"; covid-19 vaccine astrazeneca (dose 2), administration date: 27jul2021, for covid-19 immunisation. the following information was reported: off label use (medically significant), interchange of vaccine products (medically significant) all with onset 10feb2022, outcome "unknown" and all described as "covid-19 vaccine astrazeneca/comrinaty"; musculoskeletal chest pain (medically significant), condition aggravated (medically significant) all with onset 15feb2022, outcome "not recovered" and all described as "rib pain/this time is more intense and constant". the event "rib pain/this time is more intense and constant" was evaluated at the physician office visit. the patient underwent the following laboratory tests and procedures: sars-cov-2 test: (17feb2022) negative, notes: no - negative covid-19 test; scan: (unspecified date) did not detect any issues. clinical course: the patient further reported intense, constant rib pain on same side as vaccine. spoke to physician (gp) who was investigating further. similar pain was felt after dose 1 of covid vaccine and had only just begun to disappear. this time is more intense and constant. patient has not tested positive for covid-19 since having the vaccine. patient is not enrolled in clinical trial. the report does not relate to possible inflammation of the heart (myocarditis or pericarditis). scan carried out after dose 1 but did not detect any issues. no follow-up attempts are possible. no further information is expected

Lab Data
test date: 20220217; test name: covid-19 virus test; test result: negative ; comments: no - negative covid-19 test; test name: scan; result unstructured data: test result:did not detect any issues
List of symptoms
condition aggravated musculoskeletal chest pain interchange of vaccine products scan sars-cov-2 test off label use
Patient Died?
No
Date Died
NA
Birth defect
false
Vaccine Administered By:
Other
Vaccine Purchased By:
Unknown
Patient visit ER?
No
Patient Hospitalized?
No
Stay in hospital
No
Days in hospital
Unspecified
Permanent disability?
No
Allergies:
na
Current Illness
na